Showing posts with label cell therapy. Show all posts
Showing posts with label cell therapy. Show all posts

Sunday, February 8, 2015

The production of the spider silk

The structure of the silk fibre has two components , a crystalline one incorporated in the semi - amorphous region . The crystalline section contains poly – ( Gly – Ala ) , and poly – Ala nano – domains , filling in 50 % of the volume . The weak Hydrogen bonds have the functionality to link the nano – domains , in 10 – 15 % of the volume . The overall fibre is a natural block copolymer , with the elastic capacity from 500 % to 1000 % , and with the tensile strength in the GPa magnitude .

The Araneidae , a garden spider , weaves the two - dimensional web to capture insects . The web silk for this spider does not break when the insect attaches . The retraction time of the extended web spiral is small , so that the silk does not attach to unwanted elements . The silk coated naturally with a hydroscopic glue , has increased elasticity . The researchers analyse the natural phenomenon , both in the absence , and in the presence of fluid . Figure 1 summarises two experiments , a and b , conducted with the same setup , in the laboratory . The stretching curve is red , and the retraction curve is blue .

Figure 1 . The force spectra of the silk web molecules for The Araneidae ( the orb – weaving spider ) .
Copyright ( 2003 ) Nature Publishing Group

The natural method to produce silk has yet many unknowns for the researchers . The spider silk produced naturally is in limited volume . A method to produce hand - made silk , similar to the spider silk , with lower tensile strength , is from the transgenic silk worms, and from the milk of the transgenic goats .

A suitable match between the material properties of biomaterials and the ones of the cardiac tissue may be improved . A scaffold may be electrospun with the silk solution , with or without the addition of extra cellular matrix solution .

References :

Becker N . , Oroudjev E . , Mutz S . , Cleveland J . P . , Hansma P . K . , Hayashi C . Y . , Makarov D . E . , Hansma H . G . ( 2003 ) “ Molecular nanosprings in spider capture – silk threads ” , Nature Materials , 2 , 278 - 283 .

Tuesday, October 28, 2014

The longitudinal monitoring for the myocardium

The imaging techniques , in suitable parameters , provide the connection between the cell therapies and the clinical procedure . The longitudinal monitoring provides information about the functioning mechanism of the reprogrammed cells in the in vivo environment . The review presents the imaging techniques that are able to explain the cause for the limited restoration process of the cell therapies in the cardiac tissue .

The human body contains approximately 3 , 7 × 1013 cells . The heart contains 6 × 109 cells , in 300 grams ( figure 1 ) . The damage of the heart does not lead automatically to the regeneration of the full functional capacity . The scar formation and the inflammatory signals may not be enough to have a full regeneration of the cardiac tissue . The regenerative medicine enhances the healing mechanisms of the body with the cell therapy .

Figure 1 . The number of cells in the parts of the human body .
Copyright ( 2014 ) Katie Vicari / Nature Publishing Group

The minimum number of injected cells that is detectable by the imaging techniques is in the range of 104 - 106 cells . The heart contains 2 × 107 cells in one gram of tissue , in the left ventricle . The fused positron emission tomography ( PET ) - computed tomography ( CT ) image of the porcine heart is an example for the technique ( figure 2 ) . The long arrows point to the trajectory of the thoracotomy . T is the inserted tube . The short arrows point to the 108 human mesenchymal stem cells , injected in the left ventricle ( LV ) . The %ID / g is the percentage of the uptake by the injected human cells in one gram of porcine cardiac tissue .

Figure 2 . The PET - CT imaging of the expression for the reporter gene in the porcine myocardium .
Copyright ( 2009 ) RSNA

The results of a porcine model for the myocardial infarction identifies as the time for the maximum proliferation at an interval of 33 - 35 days after the injection of the mesenchymal stem cells in the myocardium .

The injected cells are not tracked in vivo if they are not labelled in vitro . The nanoparticles , as the exogeneous label , provide a strong contrast in a short acquisition time , but it is unreliable in the long - term monitoring . The incorporation process of reporter genes labels indirectly the target cell . The reporter gene in the nucleus creates reporter proteins secreted in the cytoplasm . The imaging technique detects the reporter proteins . The ideal cell label stays inside the target cells for a long time , is non - toxic , is in a concentration that is stoichiometric related to the number of target cells , and clears the system rapidly after the apoptosis of the target cells .

The challenges of the imaging techniques are the label dilution , and the cell tracking . The label dilution should remain inside the tracked cells until the apoptosis , but sometimes the dilution transfers to the host cells . The long - term tracking of the implanted cells through the imaging techniques has the challenge to quantify the number of cells from the initial implantation procedure that are alive , and the number of cells that proliferate , in the spatial and the temporal dimension .

The infarcted myocardium is trully regenerated with the aid from the cell therapies when the viable cardiac tissue in the infarct area has the volume increased , the fiber architecture is integer in structure , and the regenerated myocardium has synchronous contraction with the host .

References :

Naumova A . V . , Modo M . , Moore A . , Murry C . E . , Frank J . A . ( 2014 ) “ Clinical imaging in regenerative medicine ” , Nature Biotechnology , 32 ( 8 ) , 804 - 818 .

Willmann J . K . , Paulmurugan R . , Rodriguez - Porcel M . , Stein W . , Brinton T . J . , Connolly A . J . , Nielsen C . H . , Lutz A . M . , Lyons J . , Ikeno F . , Suzuki Y . , Rosenberg J . , Chen I . Y . , Wu J . C . , Yeung A . C . , Yock P . , Robbins R . C . , Gambhir S . S . ( 2009 ) “ Imaging gene expression in human mesenchymal stem cells : from small to large animals ” , Radiology - Radiological Society of North America , 252 ( 1 ) , 117 - 127 .

Sunday, July 6, 2014

The engineering of complex tissue structures

The laboratory of transplantation biology for regenerative medicine at The University of Gothenburg in Sweden . The research group lead by Professor Suchitra Sumitran – Holgersson designed the first engineered vein succesfully transplanted in the hepatic portal circulation of a 10 - year old female , in 2012 . A donated nine centimeters long iliac vein was used in the study . The cells of the donor were cleared from the three dimensional structure of the vein . The stem cells from the bone marrow of the patient were cultured in the laboratory . The differentiated endothelial and smooth muscle cells grew and divided onto the vessel . There was no need for using immunisuppressives .

Professor Holgersson presented her three future research directions in the talk given at Tedx in 2012 . Her research team redesiged blood vessels and the trachea , and would continue with complicated organs as the liver and the larynx . Two human organs were thrown away , and Professor Holgersson considered they should be recycled : the placenta as filling material in face cheeks and thighs , and the amniotic membrane for wrapping around areas requiring skin grafts . The animal organ , for example the pig heart , was recycled and redesigned , with the challenging task to meet the in vivo requirements .

References :

Olausson M . , Patil P . B . , Kuna V . K . , Chougule P . , Hernandez N . , Methe K . , Kullberg – Lindh C . , Borg H . , Ejnell H . , Sumitran – Holgersson S . ( 2012 ) “ Transplantation of an allogeneic vein bioengineered with autologous stem cells: a proof - of - concept study ” , The Lancet , 380 ( 9838 ) , 230 – 237 .

Monday, June 30, 2014

Cardiomyocytes for myocardial regeneration

The pumping mechanism of the heart is adjusted by the network of coronary arteries and cardiac veins . Myocardial infarction ocurs when the blood supply is disrupted . In the progressive form , this may lead to heart failure .

The repopulation of the scar is achieved through various methods . One of them is to use autologous bone marrow cells . Another strategy is to differentiate the cardiac progenitor cells ( CPC ) . A third direction is to use cardiomyocytes ( CMs ) derived from human embryonic stem cells ( hESC ) , hESCs cardiac progenitor cells ( hESC - CPC ) , human pluripotent stem cells ( hPSCs ) , or human induced pluripotent stem cells ( hiPSCs ) for the transplantation in the myocardium .

The review paper Concise review : reprogramming strategies for cardiovascular regenerative medicine : from induced pluripotent stem cells to direct reprogramming analyses more than a hundred papers . Three reprogramming strategies for the myocardial regeneration are brought in discussion ( figure 1 ) : the iPSCs technology , the partially reprogramming method and the direct set of approaches .

Figure 1 . The CMs derived from the iPSC ( top ) , the partial reprogramming ( middle ) , and the direct reprogramming technology ( below ) .

The hESCs represent the first reliable source for cardiomyocytes in vitro . The immune rejection , and the patient – or disease – specific hESCs are two challenges for the clinical allogeneic cell transplantation .

The hESCs and hiPSCs may generate beating cardiomyocytes in an inefficient method . The canonical Wnt pathway uses hiPSCs and small molecules in a more efficient signaling strategy .

Cardiomyocytes are partially reprogrammed from the iPSCs through a technology developed in 2006 . It takes a few months to differentiate the colonies of hiPSCs into the cardiac lineage . The use of partially reprogrammed cells reduces the length of time for the process to 11 – 12 days . There are also challenges for reaching the clinical practice ( figure 2 ) . Some of them are : the phenotypic heterogeneity of the differentiating CMs , the tumorigenic risk , and the poor in – vivo survival .

Figure 2 . The phases and challenges of the partially reprogrammed iPSCs method towards clinical practice .

The process of direct reprogramming of fibroblasts into induced cardiomyocyte cells ( iCMs ) is epigenetically stable . It is achieved through various combinations : by adding the Hand2 to the Gata4 , Mef2c and Tbx5 combination of transcription factors ; by using myocardin , and a combination of the Mef2c and Tbx5 transcription factors ; through a combination of a Janus inhibitor and four microRNAs ; by mixing two microRNAs and four transcription factors . The challenges of the myocardial regeneration are reduced through the deliver of reprogramming factors directly to the cardiac tissue .

Progress in the regeneration therapy is achieved if further studies are performed on early stages of myocardial infarction , if the stem cells delivered in – vivo generate efficiently new myocardium , and if the newly developed myocardium has suitable performance for the patient .